Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

This year, researchers Megan Shen, PhD, and Mary L. “Nora” Disis, MD, of Fred Hutch Cancer Center and UW Medicine ...

To optimize treatment outcomes for patients whose late-stage cancer shows resistance to the standard treatment, Sarasota Memorial Research Institute will participate in testing an experimental ...

Results from a new Phase 3 trial published in the journal npj Precision Oncology found that a cancer stem cell test can ...

Black and American Indian patients are less likely to have elevated CA-125 levels compared with White patients.

Adding afuresertib to paclitaxel did not improve outcomes in patients with platinum-resistant ovarian cancer in a phase 2 trial.

Ovarian cancer is an abnormal cell growth (tumour) arising in the ovary. The majority of ovarian cancers are epithelial and develop in women over 50. Screening is highly recommended in women with ...

Sonnet BioTherapeutics chief medical officer Richard Kenney said: “We are encouraged by the topline safety data and very ...

ovarian cancer progressing under taxane/carboplatin chemotherapy or in early relapse (< 6 months).

Researchers at Moffitt Cancer Center have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness ...

Mar. 13, 2025 — A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States ...

A leading snack brand, Utz is headquartered in Hanover and employs about 3,200 people. Utz produces salty snacks including potato chips, tortilla chips, pretzels, cheese snacks, pork skins and ...